MiMedx Group, headquartered in Marietta, Georgia, specializes in therapeutic biologics, focusing on placental tissue allografts for wound care and surgical applications. The company, founded in 2007, employs 895 staff and offers various patented products.
MDXG has been in the news recently: On June 23, multiple board members of MiMedx Group (MDXG), including Todd Newton, M. Kathleen Behrens Wilsey, James L. Bierman, William A. Hawkins, and Cato T. Laurencin, made significant insider purchases, as reported in recent SEC filings. These transactions highlight the confidence of the board members in the company's future prospects.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.